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Abstract Adult epicardial cells are required for endoge-
nous cardiac repair. After myocardial injury, they are reac-
tivated, undergo epithelial-to-mesenchymal transformation
(EMT) and migrate into the injured myocardium where they
generate various cell types, including coronary smooth
muscle cells and cardiac interstitial ﬁbroblasts, which con-
tributetocardiacrepair.Tounderstandwhatdrivesepicardial
EMT, we used an in vitro model for human adult epicardial
cells. These cells have an epithelium-like morphology and
markedly express the cell surface marker vascular cell
adhesion marker (VCAM-1). In culture, epicardial cells
spontaneously undergo EMT after which the spindle-shaped
cells now express endoglin. Both epicardial cells before and
after EMT express the epicardial marker, Wilms tumor 1
(WT1). Adding transforming growth factor beta (TGFb)
induces loss of epithelial character and initiates the onset of
mesenchymaldifferentiationin human adult epicardial cells.
Inthisstudy,weshowthatTGFb-inducedEMTisdependent
on type-1 TGFb receptor activity and can be inhibited by
soluble VCAM-1. We also show that epicardial-speciﬁc
knockdown of Wilms tumor-1 (WT1) induces the process of
EMT in human adult epicardial cells, through transcriptional
regulation of platelet-derived growth factor receptor alpha
(Pdgfra), Snai1 and VCAM-1. These data provide new
insights into the process of EMT in human adult epicardial
cells, which might provide opportunities to develop new
strategies for endogenous cell-based cardiac repair.
Keywords Epicardium   Human   Epithelial-
to-mesenchymal transformation   Transforming
growth factor beta (TGFb)   Wilms tumor 1 (WT1)
Introduction
The transformation of epithelial cells to a mesenchymal
(EMT) phenotype is an important process for proper heart
development. The development of the cardiac valves and
septa of the heart is dependent on EMT of endocardial cells
underlying the atrioventricular canal and endocardial cells
underlying the outﬂow tract forming the endocardial
cushions [16, 24, 36]. A distinct population of cells derived
from the epicardium also undergoes EMT during cardio-
genesis [30]. During embryogenesis, the epicardium orig-
inates from the proepicardial organ (PEO) recruited from
the coelomic wall mesothelium at the venous pole of the
heart. Cells derived from the PEO protrude to and cover the
primitive heart tube. A part of these epicardial cells
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(EPDCs). As a result of EMT, EPDCs migrate into the
subepicardium and subsequently into the myocardium [30,
51]. In the myocardium, EPDCs initially differentiate into
interstitial ﬁbroblasts [30] and later on into smooth muscle
cells and adventitial ﬁbroblasts of the coronary vasculature
[14, 50]. The contribution of EPDCs to heart development
is not only structural, but also have a regulatory role in
cardiogenesis. The mechanisms underlying this regulatory
process are largely unknown, although it is likely that cell–
cell communication is of importance [30].
Previous in vitro studies have identiﬁed transforming
growth factor beta (TGFb) as a key regulator of EMT in
the embryonic PEO and embryonic epicardium in both
mouse and chicken [5, 12, 16]. The TGFb-regulated EMT
of chicken embryonic epicardial cells is dependent on the
kinase activity of the TGFb type I receptor or activin
receptor-like kinase (ALK) 5 [5]. Furthermore, soluble
vascular cell adhesion molecule-1 (VCAM-1) is able to
inhibit TGFb-induced EMT [16]. Examination of the
expression patterns of other growth factors present during
embryonic development implies a role for ﬁbroblast
growth factor (FGF) and platelet-derived growth factor
(PDGF) in epicardial EMT [6, 45]. Interestingly, the
aforementioned roles of epicardial cells and EPDCs do
not seem to be restricted to embryonic development. In
the adult heart, the epicardium is a simple squamous
epithelium, which functions as a smooth surface on
which the heart slides in the pericardial cavity during
contraction [30]. Over the last few years, several studies
have focused on the role of adult epicardium and EPDCs
in heart repair. Recently, we demonstrated that human
adult spindle-shaped EPDCs, injected into the infarcted
myocardium, preserved cardiac function and reduced
remodeling both early and late after the onset of infarc-
tion [52]. These ﬁndings suggest that EPDCs could be a
suitable cell source for cardiac cell therapy. Interestingly,
recent in vivo studies showed that endogenous epicar-
dium was reactivated after a myocardial infarction,
thereby re-expressing embryonic markers such as raldh2,
Tbx18 and WT1 [19, 29, 31, 44, 52]. Furthermore, re-
activated epicardial cells proliferate and are able to
undergo EMT, and after they migrate into the injured
myocardium contribute to cardiac regeneration [19, 29,
31, 44, 52]. These studies suggest that adult epicardium is
a dynamic tissue, which is still able to generate EPDCs
that can contribute to the adult ventricular wall. More
insight into the signals that direct the process of EMT in
adult epicardial cells would be beneﬁcial for endoge-
nously regulated cell-based cardiac repair, thereby pro-
viding the opportunity to investigate the possibilities to
bypass the need for cell transplantation by stimulating
repair by endogenous cells [33].
Therefore, the aim of this study was to gain more insight
into the EMT process of human adult epicardial cells and to
determine which factors are involved in EMT of human
adult epicardium. We characterized human adult epicardial
cells in vitro before and after EMT. Here, we describe that
the cobblestone-like VCAM-1 expressing EPDCs (cEP-
DCs) upon TGFb stimulation undergo speciﬁc morpho-
logical changes including the loss of epithelial
characteristics. Spindle-shaped EPDCs (sEPDCs) have the
appearance of a smooth muscle-like morphology and
express endoglin, while VCAM-1 expression is inhibited in
an ALK5-dependent manner. Furthermore, we show that
WT1 is a repressor of the EMT process in human adult
epicardial cells. Taken together with the expression pat-
terns of TGFb and WT1 after myocardial infarction, these
new insights into the process of EMT in human adult




All experiments with human tissue specimens were carried
out according to the ofﬁcial guidelines of the Leiden
University Medical Center and with the approval of the
institutional ethical committee.
Harvesting and preparation of human epicardial cells
Cultures of human epicardial cells with an epithelium-like
morphology, also referred to as cobblestone-like EPDCs
(cEPDCs), were prepared as described previously [49].
Brieﬂy, EPDCs were cultured from the right atrial
appendages excised during cardiac surgery from several
adult patients. The layer of epicardium was stripped and
minced into small pieces. The tissue pieces were cultured
in a 1:1 mixture of Dulbecco’s modiﬁed Eagle’s medium
(DMEM low glucose) and medium 199 (M199) containing
100 U/ml penicillin, 100 lg/ml streptomycin, 10% inacti-
vated fetal calf serum (FCSi) (all from Invitrogen, Paisly,
UK), and 2 ng/ml basic ﬁbroblast growth factor (bFGF)
(Sigma-Aldrich, St. Louis, USA). The addition of bFGF
stimulated outgrowth of cells from the tissue pieces and the
proliferation of the cells. When the outgrowth of the epi-
cardial cells was conﬂuent, the cells were detached from
the bottom of the culture dish with trypsin/EDTA (Invit-
rogen) solution. The cells were seeded in high density and
cultured in a 1:1 mixture of DMEM and M199 supple-
mented with 100 U/ml penicillin, 100 lg/ml streptomycin
and 10% FCSi to maintain the epithelium-like morphology
(cobblestone-like EPDCs, cEPDCs). The medium was
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123refreshed every 3 days. Stimulation experiments were
performed with cEPDCs from passage (P) 2–4 of three
different patients. In total, we used isolations from nine
different right atrial appendages.
The purity of the human cEPDC cultures was certiﬁed
with immunohistochemical staining for Wilms tumor-1
protein (WT1) (Calbiochem, San Diego, USA) at a dilution
of 1:50.
For the in vitro stimulation experiments, cells were
plated at a density of 20,000 cells/cm
2 and were allowed to
attach for 24 h prior to the addition of growth factor or
inhibitor.
Addition of growth factors or inhibitors
The medium was supplemented with the growth factors
and inhibitors 24 h after seeding of the human adult cEP-
DCs. Growth factors TGFb3 (1 ng/ml) (R&D Systems Inc.,
Minneapolis, USA) and sVCAM-1 (100 ng/ml) (R&D
Systems) or small molecule inhibitors SB431542 (iALK5,
10 lM) (Sigma-Aldrich), a-Endoglin antibody (0.5 lg/ml)
(R&D Systems) and Y27632 (iROCK 2.33 lg/ml) (Cal-
biochem) were used. At 48 h after the addition of stimu-
lators, cells were used for further analysis by
immunohistochemical analysis, qPCR, Western blot anal-
ysis and an MTT assay.
Immunophenotyping
The surface antigen expression proﬁles of epicardial cells
(cEPDCs) and epicardium-derived cells (sEPDCs) were
determined by ﬂow cytometry as described previously [49].
The antibodies used for ﬂow cytometric analysis are listed
in Table 1.
Immunohistochemical analysis
cEPDCs were cultured on glass chamber slides and, 48 h
after stimulation, slides were subjected to immunohisto-
chemical analysis [49]. Brieﬂy, after ﬁxation and perme-
abilization with 0.1% Triton, slides were incubated
overnight with primary antibodies. The details of the
antibodies are listed in Table 1. To investigate their mor-
phology, the cells were immunoﬂuorescently stained for b-
catenin, phalloidin and a-smooth muscle actin (aSMA).
Staining for b-catenin was performed overnight to detect
cells with epithelial morphology, using an anti mouse FITC
labeled secondary antibody. Prior to incubation (1 h) with
phalloidin directly labeled with Rhodamine, cells were
blocked with 3% BSA/PBST for 45 min. For immunoﬂu-
orescence, the nuclei were stained with 40,6-diamidino-2-
phenylindole (DAPI) (diluted 1:1,000 in PBS). Finally, the
slides were mounted with Vectashield (Vector,
Burlingame, USA). Examination of the slides was per-
formed using a ﬂuorescence microscope and light micro-
scope equipped with a digital camera (Diagnostics, RT3
slider, Sterling Heights, MI, USA).
Cells that were labeled with the antibody against a-
smooth muscle actin (aSMA) were incubated with 5%
bovine serum albumin (BSA, fraction V) in PBS (30 min)
prior to the primary antibody, to block non-speciﬁc bind-
ing, Subsequently, cells were incubated in modiﬁed NET-
gel (50 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA,
0.25% gelatin and 0.05% nonidet P40) with 0.5% BSA and
an appropriate secondary antibody (see Table 1), carried
out for 2 and 1 h at room temperature, respectively. The
slides were mounted with Mowiol and analyzed using a
ﬂuorescence microscope (Zeiss Inc, New York, USA).
Table 1 Antibodies used for ﬂow cytometry and
immunohistochemistry
Antigen Source Clone Isotype Label Species
b-Catenin BD 14 IgG1 – Mouse
a/b-Tubulin CellSig – – – Rabbit
aSMA SA – IgG2a – Mouse
CD31 CLB HEC/75 IgG1 FITC Mouse
CD34 BD 8G12 IgG1 PE Mouse
CD44 BD G44-26 C26 IgG2b PE Mouse
CD46 BD E4.3 IgG2a FITC Mouse
CD90 BD 5E10 IgG1 FITC Mouse
CD105 Bio SN6 IgG1 PE Mouse
CD106 BD 51-10C9 IgG1 PE Mouse
Endoglin HM – – – Rabbit
GAPDH MP 6C5 IgG1 Mouse
Id1 SC Rabbit
Pai-1 SC Rabbit
pSmad1 HM – – – Rabbit
pSmad2 HM – – – Rabbit
VE-cadherin SC F8 IgG1 – Mouse
Vimentin SA V9 IgG1 Cy3 Mouse
WT1 CA – – – Rabbit
Goat IgG MP – – Alexa Fluor 568 Rabbit
Mouse Ig Dako – – FITC Rabbit
Mouse Ig BD – – FITC Goat
Mouse IgG1 BD X56 IgG1 PE Rat
Rabbit IgG MP – – Alexa Fluor 568 Goat
Mouse IgG2a MP – IgG2a Alexa Fluor 488 Goat
Rabbit IgG VL – – Biotin Goat
Mouse IgG VL – – Biotin Horse
All antibody preparations were used at the concentrations recommended
by the suppliers. For an explanation of the abbreviations of the antigens,
see the main text of the paper
BD BD Biosciences, Bio Biocarta, CA Calbiochem, CLB Sanquin, CellSig
Cell Signaling, Dako Dako Cytomation, HM homemade, MP Molecular
Probes, SA Sigma-Aldrich, SC Santa Cruz, VL Vector Labs, FITC ﬂuo-
rescein isothiocyanate, PE phycoerythrin
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For total protein extraction of cEPDCs under the described
culture conditions, cells were trypsinized and the cell pellet
was lysated in a sample buffer (SB) containing 10% SDS,
20% glycerol, 0,1% bromophenol blue, 5% b-mercapto-
ethanol and Tris–HCl, pH 6.8. Homogenates were size-
fractionated on 10% PAGE gels and transferred to Hybond
PVDF membranes. After blocking non-speciﬁc binding
sites, membranes were incubated overnight with the anti-
pSmad1 (previously described by Goumans et al. [22]),
pSmad2 (previously described by Goumans et al. [22]),
inhibitor of differentiation 1 (Id1), plasminogen activator
inhibitor-1 (Pai-1), endoglin (previously described by
Lebrin et al. [27]) and aSMA antibodies (Table 1) followed
by incubation with a horseradish peroxidase (HRP)-labeled
secondary antibody (goat anti-rabbit or rabbit anti-goat)
for 1 h. A competitive Western blot for GAPDH and
a/b-tubulin was performed to correct differences in protein
concentration. Chemiluminescence was induced by ECL
Advanced Detection reagent and detected by exposure to
Hyperﬁlm ECL.
MTT assay
The total number of living cells as a measure for prolif-
eration and viability was determined using a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT; Sigma-Aldrich) assay (n = 3). Cells were seeded in
quatro in 95-well plates with 20,000 cells/cm
2 and stimu-
lated as described previously. In addition, the different
cultures were incubated for 3 h with MTT (50 lg/well) in
fresh culture medium. The medium was removed and
crystallized formazan dye in the cells was solubilized by
adding dimethylsulfoxide (DMSO). Absorbance was mea-
sured at 540 nm using 690 nm as reference. Quantiﬁcation
was carried out by comparison absorbance after 48 h of
stimulation with absorbance before stimulation.
RNA interference
Endoglin was knocked down using shRNA pTER tech-
nology[46],targetingthefollowing19-nucleotidesequence:
50-GAAAGAGCTTGTTGCGCA-30 [10]. Oligonucleotides
were cloned into the pTER vector under the control of the
H1-RNA promoter. H1-RNA promoter and targeting
sequence were subsequently transferred to the pRRL-
CMV-GFP vector using PstI and XhoI sites (opposite
orientation of CMV-GFP cassette). The plasmid was then
used for lentivirus production. cEPDCs were transduced
with lentivirus expressing shRNAs that speciﬁcally
target human endoglin, as described above, and control GFP
virus. After 6 h of culturing in the presence of 8 lg/ml
polybrene,themediumwasrefreshed.Thedayafterthecells
were plated in six-well plates and 2 days after transduction,
cells were stimulated with TGFb3 (1 ng/ml) comparable to
the other stimulation experiments.
mRNA isolation and quantitative RT-PCR analysis
Total RNA from cEPDCs stimulated as described was
isolated using TriPure (Roche, Almere, The Netherlands)
following the manufacturer’s protocol. cDNA was
synthesized from 750 ng RNA per sample, using iScript
cDNA synthesis kit (Fermentas, Leon-Rot, Germany).
cDNA samples were subjected to quantitative RT-PCR
(qRT-PCR) by using SYBRgreen (Roche) and a primer
concentration of 10 lM. Primers were designed with Pri-
mer3 and qPrimerDepot (htp://primerdepot.nci.nih.gov/).
Primer sequences and annealing temperatures are available
on request. qRT-PCR was performed for the following
factors: WT1 isoform A, WT1 isoform D, TGFb1, 2, and 3,
ALK1, ALK5, VCAM-1, E-cadherin, endoglin and Snai1.
qRT-PCR reactions were run on a 7900HT Applied Bio-
systems. PCR conditions were: 10 min. at 95C followed
by 40 cycles of 30 s at 95C, 30 s annealing temperature
(60C) and 30 s at 72C. All samples were corrected for
input based on housekeeping gene b-actin, which was not
inﬂuenced by the different culture conditions (data not
shown) and normalized to unstimulated conditions.
Statistics
All data of the volume measurements are presented as
average ± SEM. The PCR data were quantiﬁed using the
2
-DDCt method, by comparing signal of the sh-RNA treated
groups with that of the control group, both relative to an
internal control, b-actin. Analysis of the qRT-PCR data
was performed with T test. Signiﬁcance was assumed when
P\0.05 using SPSS 16.0 software program (SPSS Inc.
Chicago, USA). Graphics of statistical analysis were
composed by Graphpad software. For simpliﬁcation of the
interpretation of the data, in all graphs representing the
expression of mRNA of epithelial and EMT markers
the fold inductions of the control and TGFb3-stimulation
were displayed.
Results
Analysis of cell surface marker proﬁle
We expanded human cEPDCs from several atrial append-
ages and certiﬁed the purity of the cultures by WT1 staining
(Fig. 1a,b).InbothcEPDCs(Fig. 1a)andsEPDCs(Fig. 1b),
WT1 was predominantlylocalizedinthe nuclei. Thesurface
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cytometry (Table 1). As previously reported [49], sEPDCs
abundantly expressed the TGFb co-receptor endoglin
(CD105) at their plasma membrane (Fig. 1c, d). The surface
of cEPDCs was not decorated with endoglin, but contained
substantial amounts of VCAM-1 (CD106) (Fig. 1c–e). For
the other surface markers that were tested, cEPDCs and
sEPDCs yielded similar results, i.e., hyaluronate receptor
(CD44), membrane cofactor protein of the complement
system (MCP; CD46) and major T-cell antigen (Thy1;
CD90) were present. Neither cEPDCs nor sEPDCs expres-
sed the hematopoietic marker CD34 or endothelial markers
such as platelet-endothelial cell adhesion molecule-1
(PECAM-1; CD31) and vascular endothelial (VE)-cadherin
at their cell surface (Fig. 1c).
TGFb-signaling in epicardial cells
Among the many molecules that regulate the EMT process
in many different organs, there is one common element
among them involving the TGFb superfamily. Therefore,
we examined the expression of the TGFb type I receptors,
ALK1 and ALK5, and found both ALK1 and ALK5
expressed in cEPDCs (Online Resource 1 and Fig. 2a)
conﬁrming that human cEPDCs are able to respond to
TGFb. The patterns and abbreviations used in the graphs
are depicted in Box 1 in Appendix. Interestingly, the
addition of TGFb increased the expression of ALK5 mRNA
by 1.6-fold (P\0.05) (Fig. 2a), while the expression of
ALK1 decreased by 30% (P\0.05) (Online Resource 1).
Furthermore, qRT-PCR conﬁrmed the presence of TGFb1,
TGFb2 and TGFb3 transcripts in the human adult cEPDCs
(Online Resource 2).
To test whether the TGFb-signaling pathway is func-
tional in epicardial cells, we analyzed the expression of two
deﬁned downstream targets using Western blot analysis,
Id1 and Pai-1 as downstream targets of pSmad1/5 and
pSmad2/3, respectively. We were not able to detect any Id1
protein 2 days after TGFb stimulation (data not shown),
although Pai-1 was present in all samples (Fig. 2b). The
expression of Pai-1 was increased after TGFb stimulation
and markedly reduced if the ALK5 kinase inhibitor was
added to the medium (Fig. 2b).
TGFb causes loss of epithelial character
To determine whether the TGFb-signaling pathway is
involved in EMT of human adult epicardial cells, we
examined the effect of TGFb stimulation on the epithelial
character of these cells (Fig. 3a, b). Incubating cEPDCs
with TGFb for 48 h resulted in elongation of the cells
(Fig. 3b), which is indicative for EMT. To further conﬁrm
EMT, we stained with the epithelial marker b-catenin to
mark cell–cell junctions and phalloidin to visualize ﬁla-
mentous actin. In untreated cells, b-catenin was localized
in cell junctions (adherens junctions) and actin ﬁlaments
were associated with these junctions (cortical actin
ﬁlaments) (Fig. 3a2,3). When stimulated with TGFb, the
cEPDCs showed decreased expression and cytoplasmic
redistribution of b-catenin (Fig. 3b2), while the actin ﬁla-
ments were clearly visible across the cells (stress ﬁbers)
(Fig. 3b3). These changes were consistent with the cellular
events known to occur during EMT in which dissolution of
organized cell junctions and reorganization of actin into
stress ﬁbers is needed to allow actin-myosin based con-
traction. TGFb stimulation also caused increased staining
of aSMA (Fig. 3b4), which was conﬁrmed by Western blot
analysis (Fig. 2c). Although aSMA expression increased
after TGFb stimulation, the cells still expressed WT1,
demonstrating their undifferentiated state. To further
explore this apparent loss of epithelial character, we
examined the mRNA expression of E-cadherin, VCAM-1
and Snai1 by qRT-PCR (Fig. 2e) and the expression of
endoglin by Western blot (Fig. 2c). Quantitative analysis
of the epithelial markers E-cadherin and VCAM-1 after
incubation with TGFb showed signiﬁcant decrease in
VCAM-1 expression by 97% (P\0.05), while the
expression of E-cadherin did not change signiﬁcantly
(Fig. 2e). The expression of Snai1, best known for its
induction of phenotypic changes, increased by 1.5-fold
(Fig. 2e). Western blot analysis revealed that the expres-
sion of endoglin was not altered by the addition of TGFb
(Fig. 2c). These data show that in EPDCs, TGFb causes
loss of epithelial characteristics and induces the onset of
differentiation into a smooth muscle cell phenotype.
ALK5 is required and sufﬁcient for loss of epithelial
character
To determine whether the TGFb-induced morphological
changes which we observed in human adult epicardial cells
is ALK5 dependent, we incubated cEPDCs with TGFb in
the presence or absence of the ALK5 kinase inhibitor
(iALK5), SB431542, and observed that cEPDCs stimulated
in the presence of iALK5 preserve their epithelial appear-
ance. qRT-PCR analysis conﬁrmed this epithelial pheno-
type, as the expression of E-cadherin mRNA was increased
by 107% (P\0.05) in the presence of iALK5, although
the expression of VCAM-1 decreased by 70% (P\0.05)
(Fig. 2e). Western blot analysis showed that the addition of
iALK5 markedly reduced endoglin levels (Fig. 2c). Cells
incubated simultaneously with TGFb and iALK5 did not
elongate (Fig. 3d), and b-catenin and phalloidin were
persistent at the cell junctions (Fig. 3d2,3). The decrease in
expression of VCAM-1 and the increase of Snai1 mRNA by
TGFb was completely neutralized when iALK5 was added
Basic Res Cardiol (2011) 106:829–847 833
123Fig. 1 Surface marker proﬁle of human adult epicardial cells. EPDC
cultureswerestainedusingWT1tocertifythepurityoftheculture(a,b).
Flow cytometric analysis of cultured adult human EPDCs before
(cEPDCs) and after EMT (sEPDCs) was performed (c). Histograms of
endoglin(CD105)(d)andVCAM-1(CD106)(e)areshownwithisotype
control(dashedline)andthespeciﬁcsignal(solidline).Scalebar20 lm
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markedly decreased the protein level of endoglin, compa-
rable to the addition of iALK5 alone (Fig. 2c).
RhoA in epicardial EMT
TGFb is known to activate several downstream pathways
independent of Smad-signaling, e.g., via RhoA-mediated
activation [12]. To address the potential role of RhoA in
TGFb-stimulated loss of epithelial character in human
adult epicardial cells, we inhibited the p160 rho kinase, a
downstream effector of RhoA. cEPDCs were treated with
Y27632, a speciﬁc inhibitor of p160-ROCK (rho-associ-
ated coiled-coil kinase) (iROCK) in the absence or pres-
ence of TGFb3. The addition of iROCK caused elongation
of the cells, which was accompanied with the decrease of
b-catenin and phalloidin at the cell junctions (Online
Resource 3). Stress ﬁbers were not detected by phalloidin
and also staining for aSMA was below detection levels
(Online Resource 3). Simultaneous addition of TGFb and
iROCK resulted in similar morphological changes as
addition of iROCK alone, although stress ﬁbers became
visible across the cells (Online Resource 3). These data
show that p160 rho kinase activity does not mediate the
expression of smooth muscle cell markers in response to
TGFb.
VCAM-1 and endoglin alter the cytoskeleton of human
adult EPDCs
Analysis of the cell surface marker proﬁle showed spatio-
temporal differences in VCAM-1 and endoglin expression.
As the soluble form of the a4b1-integrin ligand VCAM
(sVCAM) stimulates change in epicardial cells which
restrict EMT and the fact that endoglin is part of the TGFb-
receptor complex [4, 16], the question raised is whether
VCAM-1 and endoglin are involved in the EMT process in
human adult epicardial cells. To determine the cellular
mechanism through which VCAM-1 inhibits epicardial
EMT, we treated human adult cEPDCs with sVCAM-1 for
48 h and did not observe morphologic changes of the cells
(Fig. 4b). The expression of b-catenin mRNA was
Fig. 2 Western blot and qRT-PCR analysis. Gene expression of
cEPDCs (control; C) and cEPDCs treated with 1 ng/ml TGFb3
(T) showed that the expression of ALK5 was increased by TGFb (a).
Western blot analysis of protein samples isolated from cEPDCs
stimulated in the presence or absence of 1 ng/ml TGFb3 and
a-Endoglin probed for Pai-1 (b). As a loading control, a/b-tubulin
was used (b). Western blot analysis of aSMA and endoglin in
epicardial cells stimulated by sVCAM-1 (100 ng/ml) and a-Endoglin
(0.5 lg/ml) independent or simultaneously with TGFb3 (1 ng/ml) (c,
d). GAPDH was used as a loading control in this experiment (c, d).
Gene expression of cEPDCs and cEPDCs treated with TGFb3, iALK5
and both simultaneously. Treatment with TGFb showed signiﬁcant
decrease in epithelial markers and increase in EMT marker Snai1,
which is dependent on ALK5 kinase activity (e). *P\0.05 versus
control,
#P\0.05 versus TGFb3 stimulation. For patterns and
abbreviations see Box 1 in Appendix
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while there was a decrease in cortical actin ﬁlaments
(Fig. 4b3). qRT-PCR for the epithelial markers E-cadherin
and VCAM-1 and the EMT marker Snai1 showed that
treatment with sVCAM-1 did not signiﬁcantly change their
mRNA expression (Fig. 4d).
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intercellular adhesion, we simultaneously treated cEPDCs
with TGFb and sVCAM-1. Remarkably, the presence of
sVCAM-1 not only prevented the morphologic changes of
the cells (Fig. 4c), but also prevented the formation of
ﬁlamentous actin (Fig. 4c3) although there was alteration
of b-catenin in cell junctions (Fig. 4c2). Strikingly, qRT-
PCR data showed that the expression of E-cadherin and
Snai1 both increased signiﬁcantly by 1.8 and 6.2 times,
respectively, while the expression of VCAM-1 mRNA
decreased signiﬁcantly (83%) in the presence of TGFb and
sVCAM-1 (Fig. 4d). These data show that sVCAM-1 is
able to restrict TGFb-stimulated EMT.
Endoglin is a co-receptor modulating the TGFb signal
transduction pathway [13, 43] and is markedly present at
the surface of the epicardial cells after EMT. Endoglin has
been postulated to be involved in the cytoskeletal organi-
zation affecting cell morphology and migration [36]. To
understand if and how endoglin functions in the EMT
process, cEPDCs were incubated with an a-Endoglin
antibody (Fig. 5a). a-Endoglin did not induce morphologic
changes of cEPDCs. In cells treated with a-Endoglin, the
expression of b-catenin increased, which was accompanied
with increased expression of E-cadherin and VCAM-1 by
74 and 64% (P\0.05), respectively (Fig. 5b, c).
Fig. 3 TGFb-stimulated EMT is dependent on ALK5 kinase activity.
Transforming growth factor (TGFb) induces epithelial-to-mesenchy-
mal transformation (EMT) in human adult epicardial cells, and ALK5
is required for the effects of TGFb. Epicardial cells were treated with
1 ng/ml TGFb3, 10 lM SB431542 (iALK5) and ALK5 kinase
inhibitor for 48 h before ﬁxation. Untreated epicardial cells display
an epithelial phenotype (a) accompanied with expression of b-catenin
(a2) and phalloidin (a3) at the cell–cell borders. Cells incubated with
TGFb are elongated, have lost b-catenin expression and phalloidin
was visualized across the cells in stress ﬁbers (b1–3). Cells treated
with TGFb express aSMA consistent with a smooth muscle pheno-
type (b4). In the presence of iALK5, cells display an epithelial
phenotype (c) consistent with the untreated cells (a). Cells treated
simultaneously with TGFb and iALK5 retain expression of b-catenin
at the cell border and no phalloidin staining across the cells is present
(d). All untreated and treated cells express WT1 (a5–d5). 9100 in
a1–d1. Scale bar 20 lm
Fig. 4 sVCAM-1 inhibits cell shape changes in human adult
epicardial cells treated with TGFb3. Unstimulated cells (a) and
stimulated with sVCAM-1 (100 ng/ml) (b) and simultaneously with
TGFb3 (1 ng/ml) and sVCAM-1 (100 ng/ml) (c) are stained for
b-catenin (a2–c2) and with phalloidin to visualize ﬁlamentous actin
(a3–c3). Onset of differentiation into smooth muscle cells was
visualized by staining for aSMA (a4–c4) and the state of
differentiation was visualized by WT1 (a5–c5). The process of
EMT was conﬁrmed by qRT-PCR (d) analysis for epithelial and EMT
markers. 9100 in a1–c1. Scale bar 20 lm. *P\0.05 versus control,
#P\0.05 versus TGFb3 stimulation,
$P\0.05 stimuli versus
simultaneous TGFb3/stimuli. For patterns and abbreviations see
Box 1 in Appendix
b
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123Interestingly, Western blot analysis showed that addition of
a-Endoglin increased the protein levels of endoglin in
human EPDCs (Fig. 2c). The a-Endoglin antibody was not
able to prevent the morphologic changes induced by TGFb,
as evident by decreased b-catenin expression and an
increased expression of phalloidin (Fig. 5b). qRT-PCR
data showed a decrease in mRNA levels of VCAM-1 by
96% and increase of Snai1 by 118% (Fig. 5c). These data
show that incubating human EPDCs with an endoglin
antibody does not affect TGFb-induced EMT.
EMT in EPDCs is accompanied by a strong induction of
endoglin. To ensure that the inability of the antibody to
block TGFb-induced EMT is not caused by the high levels
of endoglin, we analyzed the effect of endoglin knockdown
on TGFb-induced EMT. Human adult cEPDCs were
transduced with a lentivirus expressing an shRNA for
human endoglin (shEndoglin) or eGFP as a control
(Fig. 6a1, b1). Transduction of cEPDCs with shRNAs did
not affect the epithelial morphology (Fig. 6a2, b2) and also
the TGFb-induced morphological changes (Fig. 6a3, b3).
EMT was conﬁrmed by qRT-PCR showing a decrease in
VCAM-1 (Fig. 6e) and increase of Snai1 mRNA (Fig. 6f).
Although endogenous endoglin levels were reduced on
both mRNA (78%, P\0.05) and protein levels (Fig. 6c,
d), the addition of TGFb3 was able to induce endoglin at
both the mRNA (2.2 times, P\0.05) and protein levels in
shEndoglin-transduced cells (Fig. 6c, d). These data show
that knockdown of endoglin is not able to restrict TGFb-
stimulated EMT and increase in endoglin expression.
Role of WT1 in the process of EMT
EMT is the onset for migration and/or differentiation of the
epicardium. Therefore, we determined the differentiation
state of the treated epicardial cells by analyzing the pres-
ence of WT1. WT1 is only expressed in epicardial cells if
they are in an undifferentiated state. Immunohistochemistry
shows that all treated epicardial cells express WT1 (Figs. 2,
3, 4, 5). To determine if the level of WT1 expression is
affected by the treatment of the cells with several stimula-
tors and inhibitors, we performed qRT-PCR analysis of
WT1 mRNA expression. We observed decrease in WT1
expression in the presence of TGFb by 68% (P\0.05)
(Fig. 7a). Simultaneous addition of TGFb with either
iALK5, sVCAM-1 or a-Endoglin caused a decrease in WT1
expression by 45, 35 and 78%, respectively (Fig. 7a).
Addition of iALK5, sVCAM-1 or a-Endoglin alone did not
change the expression of WT1 signiﬁcantly (Fig. 7a).
Fig. 5 Inhibition of endoglin
expression cannot block the
process of TGFb-stimulated
EMT. Blocking of endoglin
increased the expression of
epithelial markers (a, c). In
simultaneous treatment of
epicardial cells with TGFb and
a-Endoglin, the decrease in
epithelial and increase in
mesenchymal and EMT markers
stimulated by TGFb could not




TGFb3/stimuli. 9100 in a1–b1.
Scale bar 20 lm. For patterns
and abbreviations see Box 1 in
Appendix
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EMT and low in the presence of EMT stimulating factors,
we explored the role of WT1 in the process of EMT.
Therefore, we transduced human adult cEPDCs with
shRNAs for WT1 (shWT1). Morphological analysis showed
elongation of the WT1 knockdown cells (Fig. 7d) when
compared with the control and noncoding shRNA-trans-
duced cells (Fig. 7b, c). qRT-PCR analysis for WT1 after
transduction showed that shWT1 transduction decreased the
mRNA expression of the WT1 isoform A and isoform D by
79% (P\0.05) (Fig. 7e) and 83% (P\0.05) (Online
Resource 4), respectively. The observed elongation of the
epicardial cells was accompanied with a decrease in the
epithelial marker E-cadherin by 65% (Fig. 7f). The
expression of a4-integrin and its ligand VCAM-1 (Fig. 7g,
h) decreased by 14 and 35% (P\0.05), respectively, and
the EMT marker Snai1 was increased by 98% after trans-
duction of shWT1 (P\0.05) (Fig. 7i).
Role of platelet-derived growth factors in the process
of EMT
The platelet-derived growth factor (PDGF)-signaling
pathways were found to have a crucial role in EMT during
cancer progression, since PDGF-A and its receptor
PDGFR-a were highly elevated and secretion of PDGF-A
was induced upon TGFb-induced EMT [20, 23]. We pre-
viously showed that there was a relation between WT1 and
Pdgfra, which may affect the process of EMT [7]. Inter-
estingly, mRNA expression of WT1 in human adult EPDCs
is increased after shPdgfra transduction [7]. Furthermore,
WT1 knockdown increased the expression of Pdgfra
mRNA by 85% (P\0.05) (Fig. 7j). To address the
potential role of PDGFR-a and its ligand PDGF-A in
TGFb-stimulated loss of epithelial character and the onset
of smooth muscle differentiation in human epicardial cells,
we analyzed the expression of Pdgfa (Fig. 8a) and Pdgfra
Fig. 6 Knockdown of endoglin expression cannot block the process
of TGFb-stimulated EMT. Transduction of epicardial cells with
lentivirus expression shRNAs for control GFP virus (Control) and
human endoglin (shEndoglin) was visualized by the expression of
GFP (a1, b1) and did not affect the cell morphology (a2, b2).
Addition of TGFb caused morphological changes in both shEndoglin-
transduced cEPDCs and control (a3, b3). qRT-PCR (c) and Western
blot (d) analysis showed reduction of endogenous endoglin
expression after transduction (c, d). Addition of TGFb caused
increase in endoglin expression in both transduced and control
epicardial cells. Analysis of epithelial marker VCAM-1 (e) and EMT
marker Snai1 (f) showed that knockdown of endoglin could not
prevent the effects of TGFb on these markers. 9100 in a1–c2.
*P\0.05 versus control,
#P\0.05 TGFb3 stimulation versus
nonstimulated. C control, T TGFb3; shE shEndoglin, shTE TGFb3/
shEndoglin
Basic Res Cardiol (2011) 106:829–847 839
123(Fig. 8b) mRNA after the addition of the different stimu-
lators and inhibitors. In response to TGFb3, the expression
of Pdgfa increased by 1.5-fold, while that of Pdgfra
decreased by 70% (P\0.05) (Fig. 8). iALK5 inhibited the
effect of TGFb on the expression of Pdgfa and Pdgfra
(Fig. 8). The additions of sVCAM-1 and a-Endoglin were
840 Basic Res Cardiol (2011) 106:829–847
123not able to inﬂuence the effect TGFb had on the expression
of Pdgfa and Pdgfra.
Regulation of proliferation/viability
Several studies showed that TGFb modulates cell growth
and viability. Using an MTT assay, the total number of
living cells can be used as a measure for proliferation and
viability. We observed that addition of TGFb reduced the
number of living epicardial cells by 31% compared to
untreated cells (P\0.05) (Fig. 9). The addition of iALK5
and sVCAM-1 increased the number of living epicardial
cells by 37 and 130% (P\0.05), respectively (Fig. 9).
Simultaneously, addition of TGFb with iALK5 did not
affect the number of epicardial cells compared to untreated
cells, but there was a signiﬁcant increase compared to cells
treated with TGFb alone (Fig. 9). Stimulation with
sVCAM-1 was able to prevent the negative effect of TGFb
on the number of living cells completely and the cell
number increased by 58% (P\0.05) after simultaneous
addition (Fig. 9). Inhibition of endoglin (a-Endoglin) sig-
niﬁcantly increased the number of living epicardial cells by
39% (Fig. 9). Blocking of endoglin was not able to inhibit
the effect of TGFb, as cells treated simultaneously with
TGFb and a-Endoglin showed signiﬁcant decrease in cell
number by 38.4% (P\0.05) (Fig. 9).
Discussion
In this study, we show that human adult epicardial cells lose
their epithelial character and gain aSMA expression when
stimulated by TGFb. These effects are dependent on ALK5
kinase activity. TGFb-stimulated loss of epithelial character
in adult epicardial cells seems to be independent of endoglin
levels, but can be inhibited by induction of VCAM-1. Fur-
thermore, we show that WT1 functions in the regulation of
Pdgfra and both have a role in epicardial EMT.
Fig. 7 Role of WT1 in the EMT process of human adult epicardial
cells. Quantiﬁcation of WT1 isoform A mRNA expression in human
adult epicardial cells decreased after treatment with TGFb3( a).
Knockdown of WT1 by shRNA results in loss of epithelial character
of epicardial cells (b–d). Quantiﬁcation of WT1 mRNA expression
was signiﬁcantly reduced in epicardial cells after knockdown of WT1
(P\0.05) (e and Online Resource 3). The expression of epithelial
markers E-cadherin (f), a4-integrin (g) and VCAM-1 (h) mRNA was
decreased in epicardial cells after knockdown of WT1 (P\0.05).
The expression of EMT marker Snai1 increased signiﬁcantly after
knockdown of WT1 (P\0.05) (i). WT1 knockdown caused a
signiﬁcant decrease in Pdgfra mRNA expression (P\0.05) (j).
*P\0.05 versus control,
#P\0.05 versus TGFb3 stimulation,
$P\0.05 stimuli versus simultaneous TGFb3/stimuli. For patterns
and abbreviations see Box 1 in Appendix
Fig. 8 PDGF-signaling in EMT. Quantiﬁcation of Pdgfa (a) and
Pdgfra (b) mRNA expression in human adult epicardial cells. The
expression of Pdgfa increased (a) signiﬁcantly (P\0.05) after
treatment with TGFb3 in contrast to decrease of Pdgfra expression
(b)( P\0.05). Addition of sVCAM-1 or a-Endoglin was not able to
block the effect of TGFb3o nPdgfa (a) and Pdgfra (b) mRNA
expression (P\0.05). *P\0.05 versus control,
#P\0.05 versus
TGFb3 stimulation,
$P\0.05 stimuli versus simultaneous TGFb3/
stimuli. For patterns and abbreviations see Box 1 in Appendix
Fig. 9 Quantiﬁcation of the number of epicardial cells by a MTT
assay. TGFb3 reduced the number of epicardial cells. Stimulation by
inhibition of ALK5 (iALK5) and endoglin (a-Endoglin) induced the
number of cells, as also did the addition of sVCAM-1. Simultaneous
addition of TGFb3 and iALK5 did not alter cell numbers compared to
control and was able to block the effect of TGFb3. Addition of
sVCAM-1 was also able to block the effect of TGFb3 and
signiﬁcantly increased the total cell number. Inhibition of a-Endoglin
was not able to block the effect of TGFb3 and the number of
epicardial cells reduced. *P\0.05 versus control,
#P\0.05 versus
TGFb3 stimulation,
$P\0.05 stimuli versus simultaneous TGFb3/
stimuli. For patterns and abbreviations see Box 1 in Appendix
b
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123Our data demonstrate a role for the TGFb/ALK5 sig-
naling pathway in the regulation of EMT of human adult
epicardial cells and in the onset of differentiation. The
switch from VCAM-1 positive cEPDCs to endoglin
expressing sEPDCs is accompanied with downregulation
of VCAM-1, which triggers EMT. These new insights into
the process of EMT in human adult epicardial cells may
help to develop new therapies for cardiac repair, focused
on modulation of VCAM-1 and WT1.
Adult EPDCs express VCAM-1 before, but endoglin
after, EMT
Epicardial cells isolated from adult atrial appendages
changed morphologically during EMT, which was
accompanied by a reduction of b-catenin levels. More
interestingly, while cEPDCs were characterized by
expression of VCAM-1 on their cell surface and an absence
of endoglin, sEPDCs did express endoglin and were neg-
ative for VCAM-1. Previous studies revealed that VCAM-1
restricts TGFb-stimulated EMT by inhibiting TGFb-med-
iated loss of b-catenin from intercellular junctions and
enhances cell–cell adhesion [16]. Therefore, the expression
of VCAM-1 and b-catenin are supportive for the epithelial
nature of cEPDCs. Epicardial cells lose their epithelial
characteristics under the inﬂuence of TGFb [5, 12].
Endoglin is an ancillary TGFb co-receptor expressed on
mesenchymal stem cells [40] and smooth muscle cells [10]
and is involved in EMT [13, 43]. Together with the
decreased expression of b-catenin at the plasma membrane
of sEPDCs, endoglin expression in sEPDCs conﬁrms EMT.
Human adult epicardial EMT in vitro
Our data demonstrate that TGFb-signaling induces loss of
epithelial character of human adult cEPDCs and the onset
of differentiation toward ﬁbroblasts and/or smooth muscle
cells, as previously reported for embryonic mouse and
chicken epicardial cells [5, 12, 16] and human mesothelial
epicardial cells [15]. As TGFb is expressed in the injured
myocardium [11, 17, 42], reactivated epicardial cells
probably undergo EMT and invade into the myocardium
due to the local availability of active ligand. In all exper-
imental conditions, human adult epicardial cells also
express WT1, conﬁrming their undifferentiated stage.
All human TGFb isoforms (TGFb1-3) signal by binding
to a heterotetrameric complex of transmembrane serine/
threonine kinase receptors [21]. Upon ligand binding to the
TGFb type II receptor (TGFbRII), the type I receptor
(TGFbRI or ALK5) is recruited into the complex and
phosphorylated. The activated TGFbRI kinase transduces
the signal into the nucleus by phosphorylating Smad pro-
teins required for EMT [1, 24]. There is a third class of
TGFb receptors, namely the co-receptors b-glycan and
endoglin. Addition of TGFb increased ALK5 expression
and decreased the expression of another type I receptor
ALK1. Also, the levels of Pai-1 were elevated, a known
downstream target of the ALK5/Smad2/3-signaling cas-
cade, and inhibition of the ALK5 kinase decreased Pai-1
expression, also conﬁrming that EMT in human adult
epicardial cells is regulated via the TGFb/ALK5 pathway.
Increased expression of ALK5 mRNA after TGFb stimu-
lation suggests a feed-forward loop.
The addition of TGFb resulted in decreased number of
human adult epicardial cells, suggesting less proliferation
or cell viability. Previous studies using endothelial cells
(ECs) showed that TGFb inhibits the proliferation of ECs
via the ALK5 pathway, while the ALK1-signaling cascade
is responsible for the activation of proliferation [22, 27].
Although both type 1 receptors are expressed in epicardial
cells, only the ALK5 pathway is necessary for TGFb-
induced EMT.
VCAM-1 antagonizes TGFb-induced EMT in adult
epicardial cells
Soluble VCAM-1 treatment inhibited TGFb-dependent
loss of E-cadherin expression and preserved their epithelial
character. Dokic et al. [16] reported that sVCAM-1 treat-
ment leads to events that increase cortical actin association
with the adherens junction and stabilizes adherens junction
components at the membrane in embryonic chicken epi-
cardial cells and rat epicardial mesothelial cells (EMCs).
The presence of sVCAM-1 stabilizes the cell–cell contacts
on the cell membrane, thereby preventing morphological
changes. However, the TGFb-induced decrease in VCAM-1
mRNA expression and the increase of Snai1 mRNA could
not be blocked by sVCAM-1. One explanation could be
that the change in gene expression and the loss of epithelial
character are stimulated via different signaling pathways.
In endothelial cells, TGFb can transduce a signal using two
pathways [22], the TGFb/ALK5 pathway phosphorylating
Smad2/3 and the TGFb/ALK1 pathway activating Smad1.
Interestingly, VCAM-1 is associated with Smad1, as
Smad1
-/- embryos lack the expression of VCAM-1 in the
placenta [28]. Furthermore, human umbilical vein endo-
thelial cells infected with constitutively active ALK1
increased the expression of VCAM-1, while constitutively
active ALK5 reduced its expression [37]. These observa-
tions indicate that the ability of VCAM-1 to alter TGFb-
stimulated EMT probably depends on the stability of
adherence junctions, while the TGFb/ALK5 and TGFb/
ALK1 pathways are involved in regulating the expression
of target genes, such as VCAM-1 and Snai1, and regulate
the actual process of EMT. Future research needs to
demonstrate if, like in endothelial cells, ALK1 is activated
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1 is able to activate TGFb/ALK1 signaling. The upregu-
lation of Snai1 seen in simultaneous stimulation of
epicardial cells by TGFb3 and sVCAM-1 is most likely
regulated by the ALK5 pathway. Further studies of the
signaling pathways altered by VCAM-1 and the modula-
tion of VCAM-1 in human adult epicardial cells should
allow us to elucidate the role of VCAM-1 in TGFb-induced
EMT.
The role of endoglin in EMT of adult epicardial cells
The presence of endoglin on the surface of epicardial cells
that underwent EMT, suggested a role for endoglin in the
process of EMT. This was supported by Mercado-Pimental
et al. [36] who showed that loss of endoglin resulted in a
direct perturbation of EMT during cardiac valve formation
and reduced the expression of EMT markers including slug
and Runx2. However, in our study, blocking of endoglin
function by addition of a-Endoglin antibody did not inhibit
TGFb-induced EMT of the EPDCs. One explanation for
the discrepancy compared to the study of Mecado-Pimental
et al. [36] is the availability of endoglin for signaling.
Using the antibody, we might not be able to occupy all
receptors on the cell surface. shRNA knockdown of
endoglin in human adult epicardial cells also did not
restrict TGFb-induced morphologic changes in epicardial
cells. These data suggest that endoglin is not directly
involved in the initiation process of EMT in EPDCs as is
shown for endothelial cells [27, 39], but might be beneﬁcial
for differentiation further on in the EMT-pathway.
Wilms tumor suppressor WT1 and Pdgfra
WT1 is a novel transcriptional activator of the a4-integrin
gene and stimulation of a4-integrin expression by WT1
may promote cell adhesion in the epicardium [26]. Our
data show that knockdown of WT1 in human epicardial
cells stimulated the loss of epithelial morphology and
reduced expression of E-cadherin, a4-integrin and VCAM-
1 signiﬁcantly, while the expression of Snai1 increased
signiﬁcantly. This suggests that WT1 is a repressor of the
EMT process in adult epicardial cells. These ﬁndings are
consistent with previous described data of Bergmann and
Kirschner [8, 26]. Bergmann et al. described that WT1
transcriptionally represses TGFb [8], and Kirschner et al.
described that WT1 transcriptionally activates a4-intergrin
[26]. These data are similar to our observation, but opposite
to the data described by Martinez-Estrada et al. [34].
Martinez-Estrada et al. generated immortalized tamoxifen-
inducible WT1-knockout epicardial cells (Cre?CoMEEC,
E11.5). CoMEECs had typical cobblestone morphology
and showed robust WT1 expression. Loss of WT1 after
tamoxifen treatment led to a robust increase in E-cadherin
expression and was associated with downregulation of
N-cadherin, Snai1 and aSMA [34]. The contradiction
between our data and Martinez-Estrada et al. could very
well be caused by the fact that EMT in human adult epi-
cardial cells is regulated by other factors compared to EMT
in mouse embryonic epicardial cells. Further research is
needed to elucidate the exact role of WT1 in the process of
EMT in human adult epicardial cells.
Knockdown of WT1 and Pdgfra [7] suggested that there
was a possible relation between these two factors. Previous
study showed that both factors could inhibit the other factor
in a signiﬁcant manner, as shWT1 increased the Pdgfra
expression and shPdgfra increased the expression of WT1
in human adult epicardial cells [7]. PDGF-signaling is
known to support epicardial EMT. Both PDGF receptors,
Pdgfra and Pdgfrb, are expressed in the epicardium [6, 35,
47]; PDGF-BB, which can bind to both Pdgfra and Pdgfrb,
is more potent in inducing cultured embryonic quail
epicardial cells to undergo the initial steps of EMT [32]
compared to both PDGF-AA and PDGF-AB, suggesting
that this pathway is involved in epicardial EMT. A previ-
ous study showed an EMT-inducing role for Pdgfra in
mouse embryonic epicardial cells [7], as the receptor is
able to repress WT1 expression. Unpublished data by
Smith suggest that both receptors are required for the
development of a unique epicardial derivative, Pdgfra, for
cardiac ﬁbroblast and Pdgfrb for smooth muscle cells. This
is in agreement with earlier observations that show that
Pdgfra is more related to myocardial differentiation, while
Pdgfrb is expressed during the stage of coronary artery
formation [48]. Furthermore, PDGF-signaling stimulated
the phosphorylation of Sox9 and combined with TGFb
induces a transcriptional complex with Smad2 and Snai1
(Smith et al. personal communication). A previous study
shows that WT1 is required for Sox9 expression [18] and
that the expression of Sox9 is involved in the process of
EMT during cardiac cushion development [2]. We show
that during the process of EMT both WT1 and Pdgfra are
involved and more elaborate studies will be necessary to
further explore the link between both growth factors and
TGFb, Sox9, Smad2 and Snai1 and their potential roles in
human adult epicardial EMT.
Interestingly, a role for PDGF-signaling in EMT is
suggested in hepatocarcinogenesis, since PDGF-A ligand
and PDGF receptor subunits were highly elevated upon
TGFb-induced EMT [20]. Our data show that an increase
of Pdgfa mRNA expression is accompanied by a decrease
in Pdgfra expression. This negative relation between
PDGF-A and PDGFR-a has been previously described in
chicken embryos in which epicardial outgrowth was
inhibited [6]. Furthermore, Paulsson et al. [38] described
that there was a density-dependent inhibitory effect of
Basic Res Cardiol (2011) 106:829–847 843
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TGFb-regulated decrease of Pdgfra could also be due to an
excess of TGFb-ligand. Future research on the role of
Pdgfra mediated by TGFb and/or WT1 in the EMT process
is needed to be able to fully understand this intriguing
cascade.
Regenerative medicine
Epicardial cells are a promising tool with regard to car-
diac regeneration therapy. Transplantation of exogenous
human adult EPDCs into the ischemic mouse myocardium
improved left ventricular (LV) ejection fraction. Adverse
remodeling was also attenuated by EPDCs injection [52].
The importance of epicardial cells and EPDCs for cardi-
ogenesis and regenerative medicine is related to their role
in coronary vessel development and maintenance of
myocardial architecture [19, 29, 31, 44, 52]. Activation of
endogenous epicardium stimulates the process of EMT,
by which cells can migrate into the myocardium. Reac-
tivation of the embryonic program of epicardial cells after
myocardial injury is of great importance for the process
of intrinsic cardiac repair. Understanding more of the
process of EMT and the involved pathways in human
adult epicardial cells is important for the development of
strategies to stimulate heart repair by endogenous cell
sources.
The members of the TGFb superfamily are markedly
induced in the infarcted myocardium and through their
potent effects are capable of playing a central role in infarct
healing and cardiac repair [11, 17, 42]. Our data combined
with previous studies suggest that TGFb is not only a
central mediator involved in the inﬂammatory and ﬁbrotic
phase of healing and may critically modulate many cellular
steps in post-infarction cardiac repair [11, 17, 42], but can
also induce EMT of epicardial cells.
Thymosin beta 4 (Tb4) is reported to activate endoge-
nous mouse adult epicardium after myocardial infarction
[41, 44]. This, combined with the knowledge from previous
studies that Tb4 signiﬁcantly increase the expression of
TGFb [9] and that Tb4 increases the secretion of Pai-1 in
endothelial cells [3], suggests that Tb4 could be the initi-
ator for the onset of the EMT-regulated pathway in adult
epicardial cells (Fig. 10). Therefore, Tb4 might elevate
TGFb, thereby inducing EMT of epicardial cells and it
would be very interesting to see if the effects of TGFb on
VCAM-1, WT1 and Pdgfra during EMT in human adult
epicardial cells are initiated by Tb4. Future research in
cardiac repair, focusing on the potential of the TGFb/
ALK5 pathway initiating EMT of endogenous human adult
epicardial cells investigation via transcriptional regulation
of WT1 and Pdgfra, might provide new treatment
modalities.
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Fig. 10 Epithelial-to-mesenchymal transformation (EMT) of human
adult epicardial cells. Master regulator of EMT, Snai1, leads to
dramatic changes in gene expression proﬁle and cellular morphology.
Snai1 represses the expression of epithelial markers and triggers the
expression of EMT markers. Herewith, we depict a possible pathway,
which stimulates epicardial EMT after myocardial injury (adapted
from Kang et al. [25]. Arrows with arrowheads represent activation
and arrows with bullets represent repression. Dashed arrow lines with
arrowheads and bullets represent indicative pathways
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